Zuranolone for Postpartum Depression

<p>Should zuranolone be a first-line treatment for postpartum depression? In this episode, Dr. Phelps discusses a randomized trial of zuranolone—a new neuromodulatory steroid—in the context of previous guidelines for the treatment of postpartum depression. </p> <p>Faculty: Jim Phelps, M.D. <br /> Host: Jessica Diaz, M.D.</p> <ul> <li><strong><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159"> Learn more about our memberships here</a></strong></li> <li><strong><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-35-2632?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159"> Earn 0.5 CMEs: Quick Take Vol. 35</a><br /></strong></li> <li><strong><a href= "https://psychopharmacologyinstitute.com/section/effect-of-zuranolone-vs-placebo-in-postpartum-depression-2632-5166?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159"> Effect of Zuranolone vs Placebo in Postpartum Depression</a></strong></li> </ul> <p> </p>